Trial Profile
Comparative Study of Dapagliflozin Versus Glibenclamide Effect on Endothelial Function of Coronary Artery Disease Patients
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 07 Apr 2022
Price :
$35
*
At a glance
- Drugs Dapagliflozin (Primary) ; Glibenclamide; Metformin
- Indications Carotid artery diseases; Coronary artery disease; Type 2 diabetes mellitus
- Focus Pharmacodynamics
- Acronyms ADDENDA
- 21 Mar 2019 Status changed from not yet recruiting to completed.
- 05 Oct 2016 New trial record